Biomea Fusion Current Valuation vs. Total Debt
| BMEA Stock | USD 7.24 0.22 3.13% |
For Biomea Fusion profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biomea Fusion to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biomea Fusion utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biomea Fusion's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biomea Fusion over time as well as its relative position and ranking within its peers.
Biomea |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.01) | Return On Assets (0.56) | Return On Equity (1.05) |
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biomea Fusion Total Debt vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biomea Fusion's current stock value. Our valuation model uses many indicators to compare Biomea Fusion value to that of its competitors to determine the firm's financial worth. Biomea Fusion is rated third in current valuation category among its peers. It also is rated third in total debt category among its peers making up about 0.06 of Total Debt per Current Valuation. The ratio of Current Valuation to Total Debt for Biomea Fusion is roughly 17.10 . The current year's Total Debt To Capitalization is expected to grow to 0.02. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomea Fusion's earnings, one of the primary drivers of an investment's value.Biomea Current Valuation vs. Competition
Biomea Fusion is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 2.96 Billion. Biomea Fusion holds roughly 176.01 Million in current valuation claiming about 6% of equities under Health Care industry.
Biomea Total Debt vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Biomea Fusion |
| = | 176.01 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Biomea Fusion |
| = | 10.3 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Biomea Total Debt vs Competition
Biomea Fusion is rated third in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 85.01 Million. Biomea Fusion retains roughly 10.3 Million in total debt claiming about 12% of equities under Health Care industry.
Biomea Fusion Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biomea Fusion, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biomea Fusion will eventually generate negative long term returns. The profitability progress is the general direction of Biomea Fusion's change in net profit over the period of time. It can combine multiple indicators of Biomea Fusion, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.1 K | -1.2 K | |
| Net Interest Income | 8.9 M | 9.3 M | |
| Interest Income | 8.9 M | 9.3 M | |
| Operating Income | -126.1 M | -119.8 M | |
| Net Loss | -117.3 M | -111.4 M | |
| Income Before Tax | -117.3 M | -111.4 M | |
| Total Other Income Expense Net | 8.9 M | 9.3 M | |
| Net Loss | -73.6 M | -70 M | |
| Net Loss | -117.3 M | -111.4 M | |
| Income Tax Expense | -1.6 M | -1.5 M | |
| Non Operating Income Net Other | 1.6 M | 1.4 M | |
| Change To Netincome | 11.9 M | 12.5 M | |
| Net Loss | (3.44) | (3.61) | |
| Income Quality | 0.82 | 0.96 | |
| Net Income Per E B T | 1.12 | 1.08 |
Biomea Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biomea Fusion. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biomea Fusion position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biomea Fusion's important profitability drivers and their relationship over time.
Use Biomea Fusion in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.Biomea Fusion Pair Trading
Biomea Fusion Pair Trading Analysis
The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biomea Fusion position
In addition to having Biomea Fusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
To fully project Biomea Fusion's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biomea Fusion at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biomea Fusion's income statement, its balance sheet, and the statement of cash flows.